Horizon Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Horizon Wealth Management's NVS Position: Q1 2026 in Review
Horizon Wealth Management increased its Novartis (NVS) stake by 1.9% in Q1 2026, buying an estimated $6.9K and bringing the position to 2,399 shares worth $366K. The position accounts for 0.05% of the portfolio, ranked #98.
Horizon Wealth Management first reported a position in NVS in Q1 2023 and has held it in 13 quarters since. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Horizon Wealth Management held 2,399 shares of Novartis worth $366K as of Q1 2026.
- Horizon Wealth Management bought 45 Novartis shares in Q1 2026, an estimated $6.9K.
- Novartis made up 0.05% of Horizon Wealth Management's portfolio in Q1 2026, its #98 holding.
- Horizon Wealth Management first reported a position in Novartis in Q1 2023 and has held it in 13 quarters since.
- 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Horizon Wealth Management's 13F filing for Q1 2026, filed 24 Apr 2026.